The single nucleotide polymorphism g.1548A >g (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer

Tumor Biology

Volumn 33, Issue 5, 2012, Pages 1429-1436

  Thanopoulou, Eirini ^a   Kotzamanis, George ^a   Pateras, Ioannis S ^a   Ziras, Nicholaos ^b   Papalambros, Alexandros ^a   Mariolis Sapsakos, Theodoros ^c   Sigala, Fragiska ^c   Johnson, Elizabeth ^a   Kotsinas, Athanassios ^a   Scorilas, Andreas ^c   Gorgoulis, Vassilis G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

g.1548A >G; ICAM 1; K469E polymorphism; Non small cell lung cancer; p53

Indexed keywords

DNA; INTERCELLULAR ADHESION MOLECULE 1; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P53;

ADULT; AGED; ALTERNATIVE RNA SPLICING; APOPTOSIS; APOPTOTIC INDEX; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ICAM 1 GENE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NICK END LABELING; ONCOLOGICAL PARAMETERS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLIFERATION INDEX; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; TRANSCRIPTION REGULATION;

EID: 84868115870     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0393-4     Document Type: Article

References (36)

1. Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med. 2000;28:1379-86.
2. Yasuda M, Tanaka Y, Tamura M, Fujii K, Sugaya M, So T, Takenoyama M, Yasumoto K. Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase. Cancer Res. 2001;61:2022-30.
3. Anikeeva N, Somersalo K, Sims TN, Thomas VK, Dustin ML, Sykulev Y. Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes. Proc Natl Acad Sci USA. 2005;102:6437-42.
4. Roland CL, Harken AH, Sarr MG, Barnett Jr CC. ICAM-1 expression determines malignant potential of cancer. Surgery. 2007;141:705-7.
5. Lin YC, Shun CT, Wu MS, Chen CC. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappa b. Clin Cancer Res. 2006;12:7165-73.
6. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, Ekblom J, Denissenko MF. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis. 2005;26:943-50.
7. Hayes SH, Seigel GM. Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues. Int J Clin Exp Pathol. 2009;2:553-60.
8. Brooks KJ, Coleman EJ, Vitetta ES. The antitumor activity of an anti-cd54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. Int J Cancer. 2008;123:2438-45.
9. Mendez MP, Morris SB, Wilcoxen S, Du M, Monroy YK, Remmer H, Murphy H, Christensen PJ, Paine 3rd R. Disparate mechanisms of SICAM-1 production in the peripheral lung: contrast between alveolar epithelial cells and pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2008;294:L807-14.
10. Hu X, Barnum SR, Wohler JE, Schoeb TR, Bullard DC. Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis. Mol Immunol. 2010;47:1692-700.
11. Guney N, Soydinc HO, Derin D, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E. Serum levels of intercellular adhesion molecule ICAM-1 and e-selectin in advanced stage non-small cell lung cancer. Med Oncol. 2008;25:194-200.
12. Sprenger A, Schardt C, Rotsch M, Zehrer M, Wolf M, Havemann K, Heymanns J. Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases. J Cancer Res Clin Oncol. 1997;123:632-8.
13. Dowlati A, Gray R, Sandler AB, Schiller JH, Johnson DH. Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab-an Eastern Cooperative Oncology Group study. Clin Cancer Res. 2008;14:1407-12.
14. Iwao M, Morisaki H, Morisaki T. Single-nucleotide polymorphism g.1548g>a (e469k) in human ICAM-1 gene affects mRNA splicing pattern and TPA-induced apoptosis. Biochem Biophys Res Commun. 2004;317:729-35.
15. Holder AL, Wolf S, Walshe C, Pandya P, Stanford RE, Smith JD, Rose ML, Lawson C. Expression of endothelial intercellular adhesion molecule-1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum Immunol. 2008;69:71-8.
16. Sanadgol N, Nikravesh A, Motalleb G, Roshanzamir F, Balazade T, Ramroodi N, Khajeh H. Evaluation of the association between ICAM-1 gene polymorphisms and SICAM-1 serum levels in multiple sclerosis (MS) patients in Southeast Iran. Int J Genet Mol Biol. 2011;3:81-6. doi: 81.
17. Gorgoulis VG, Zacharatos P, Kotsinas A, Kletsas D, Mariatos G, Zoumpourlis V, Ryan KM, Kittas C, Papavassiliou AG. P53 activates ICAM-1 (cd54) expression in an nf-kappab-independent manner. EMBO J. 2003;22:1567-78.
18. Arandi N, Talei A, Erfani N, Ghaderi A. Intercellular adhesion molecule-1 genetic markers (+241g/a and +469a/g) in Iranian women with breast cancer. Cancer Genet Cytogenet. 2008;183:9-13.
19. Howell WM, Rose-Zerilli MJ, Theaker JM, Bateman AC. ICAM-1 polymorphisms and development of cutaneous malignant melanoma. Int J Immunogenet. 2005;32:367-73.
20. Theodoropoulos G, Papaconstantinou I, Felekouras E, Nikiteas N, Karakitsos P, Panoussopoulos D, Lazaris A, Patsouris E, Bramis J, Gazouli M. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol. 2006;12:5037-43.
21. Burim RV, Teixeira SA, Colli BO, Peria FM, Tirapelli LF, Marie SK, Malheiros SM, Oba-Shinjo SM, Gabbai AA, Lotufo PA, Carlotti-Junior CG. ICAM-1 (lys469glu) and PECAM-1 (leu125val) polymorphisms in diffuse astrocytomas. Clin Exp Med. 2009;9:157-63.
22. Chen H, Hernandez W, Shriver MD, Ahaghotu CA, Kittles RA. ICAM gene cluster SNPs and prostate cancer risk in African Americans. Hum Genet. 2006;120:69-76.
23. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio Jr RA, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005;434:907-13.
24. Kotsinas A, Evangelou K, Sideridou M, Kotzamanis G, Constantinides C, Zavras AI, Douglass CW, Papavassiliou AG, Gorgoulis VG. The 3′ utr igf2r-a2/b2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer. Cancer Lett. 2008;259:177-85.
25. Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. Berlin: Springer; 2010. 646 pp.
26. Gbadegesin RA, Watson CJ, Cotton SA, Brenchley PE, Webb NJ. A PCR-RFLP typing method for adhesion molecule gene polymorphisms and allele frequencies in a normal UK population. Eur J Immunogenet. 2002;29:109-11.
27. Cox DG, Hankinson SE, Hunter DJ. Polymorphisms in the ICAM gene locus are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:178-9.
28. Kammerer S, Roth RB, Reneland R, Marnellos G, Hoyal CR, Markward NJ, Ebner F, Kiechle M, Schwarz-Boeger U, Griffiths LR, Ulbrich C, Chrobok K, Forster G, Praetorius GM, Meyer P, Rehbock J, Cantor CR, Nelson MR, Braun A. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res. 2004;64:8906-10.
29. Lu ZX, Jiang P, Cai JJ, Xing Y. Context-dependent robustness to 5′ splice site polymorphisms in human populations. Hum Mol Genet. 2011;20:1084-96.
30. Oh HM, Lee S, Na BR, Wee H, Kim SH, Choi SC, Lee KM, Jun CD. RKIKK motif in the intracellular domain is critical for spatial and dynamic organization of ICAM-1: functional implication for the leukocyte adhesion and transmigration. Mol Biol Cell. 2007;18:2322-35.
31. Greenwood J, Amos CL, Walters CE, Couraud PO, Lyck R, Engelhardt B, Adamson P. Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for t lymphocyte-mediated signaling and migration. J Immunol. 2003;171:2099-108.
32. Eyles J, Puaux AL, Wang X, Toh B, Prakash C, Hong M, Tan TG, Zheng L, Ong LC, Jin Y, Kato M, Prevost-Blondel A, Chow P, Yang H, Abastado JP. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest. 2010;120:2030-9.
33. Gho YS, Kim PN, Li HC, Elkin M, Kleinman HK. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res. 2001;61:4253-7.
34. Lane DP. Cancer. P53, guardian of the genome. Nature. 1992;358:15-6.
35. Hunter KW. Host genetics and tumour metastasis. Br J Cancer. 2004;90:752-5.
36. Lewis JM, Truong TN, Schwartz MA. Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci USA. 2002;99:3627-32.